{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-22-000131","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2022-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.356704+00:00","generated_at":"2026-06-22T07:23:46.879494+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardinal Health Q1 FY23 revenue up 13% to $49.6B; GAAP EPS $0.40, non-GAAP EPS $1.20; Medical segment posts loss","bullets":["GAAP operating earnings $137M, including $154M goodwill impairment; GAAP diluted EPS $0.40, down 57% YoY.","Non-GAAP operating earnings $423M (-20% YoY); non-GAAP diluted EPS $1.20 (-7% YoY).","Pharmaceutical segment profit up 6% to $431M; Medical segment loss of $8M vs $123M profit prior year.","Revised FY23 Medical segment profit outlook to flat to 20% decline; reaffirms non-GAAP EPS guidance $5.05-$5.40.","Updated FY23 interest/other expense to $140M-$160M, non-GAAP tax rate 23%-24%, diluted shares ~262-264M."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-22-000131","json":"https://secwatch.observer/filing/0000721371-22-000131.json","markdown":"https://secwatch.observer/filing/0000721371-22-000131.md","text":"https://secwatch.observer/filing/0000721371-22-000131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/0000721371-22-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/cah-20221104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:23:46.879494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70639b1e0900caeaf1f07b08faf749b3351d8bb2","claim":"CARDINAL HEALTH INC reported the quarter ended September 30, 2022 results: revenue $49.6 billion, net income $110 million, EPS $0.40. Guidance reaffirmed.","evidence_excerpt":"Cardinal Health Reports First Quarter Fiscal 2023 Results • Revenue increased 13% to $49.6 billion • GAAP 1 operating earnings were $137 million, GAAP diluted EPS were $0.40 • Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical segment profit, partially offset by an increase in Pharmaceutical segment profit; non-GAAP diluted EPS decreased 7% to $1.20 • Company reaffirmed fiscal year 2023 non-GAAP EPS guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000131/0000721371-22-000131-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$49.6 billion"},{"label":"Net income","value":"$110 million"},{"label":"EPS","value":"$0.40"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}